646.44澳幣4.89(0.76%)
2023/03/30更新
績效 / 1月2.89%
3月5.09%
1年6.11%
晨星評等-
- 1.現金2.71%
- 2.股票14.79%
- 3.債券0.29%
- 4.其他82.21%
- 1.美國82.89%
- 2.歐洲不包含歐元區5.89%
- 3.加拿大5.03%
- 4.歐元區2.54%
- 5.新興亞洲0.89%
- 1.Vertex Pharmaceuticals Inc6.04%
- 2.Biogen Inc5.32%
- 3.argenx SE ADR4.99%
- 4.Regeneron Pharmaceuticals Inc4.37%
- 5.Biomarin Pharmaceutical Inc4.17%
- 6.Seagen Inc Ordinary Shares4.03%
- 7.Amicus Therapeutics Inc3.43%
- 8.Incyte Corp3.18%
- 9.Sarepta Therapeutics Inc3.11%
- 10.Natera Inc3.11%
- 1.現金2.71%
- 2.股票14.79%
- 3.債券0.29%
- 4.其他82.21%
- 1.美國82.89%
- 2.歐洲不包含歐元區5.89%
- 3.加拿大5.03%
- 4.歐元區2.54%
- 5.新興亞洲0.89%
- 1.Vertex Pharmaceuticals Inc6.04%
- 2.Biogen Inc5.32%
- 3.argenx SE ADR4.99%
- 4.Regeneron Pharmaceuticals Inc4.37%
- 5.Biomarin Pharmaceutical Inc4.17%
- 6.Seagen Inc Ordinary Shares4.03%
- 7.Amicus Therapeutics Inc3.43%
- 8.Incyte Corp3.18%
- 9.Sarepta Therapeutics Inc3.11%
- 10.Natera Inc3.11%